Keating Financial Advisory Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Keating Financial Advisory Services's NVS Position: Q2 2026 in Review
Keating Financial Advisory Services reduced its Novartis (NVS) stake by 69% in Q2 2026, selling an estimated $4.65K and leaving 14 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1912.
Keating Financial Advisory Services first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.6K in Q4 2025. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Keating Financial Advisory Services held 14 shares of Novartis worth $2.19K as of Q2 2026.
- Keating Financial Advisory Services sold 31 Novartis shares in Q2 2026, an estimated $4.65K.
- Novartis made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1912 holding.
- Keating Financial Advisory Services first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
- Keating Financial Advisory Services's Novartis position peaked at $23.6K in Q4 2025.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.